US 7737266
RNAi modulation of SCAP and therapeutics uses thereof
granted A61PA61P1/00A61P1/16
Quick answer
US patent 7737266 (RNAi modulation of SCAP and therapeutics uses thereof) held by The Board of Regents of the University of Texas System expires Mon Jun 10 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Jun 15 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 10 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61P, A61P1/00, A61P1/16, A61P3/00, A61P3/04